Blog

This article was originally published in Devex. Poor-quality medicine: A global pandemic By Devex Editor // 29 June 2017 Each year, the proliferation of substandard and falsified medicines puts the lives of millions of people — particularly those living in developing countries — at risk. According to the International Federation of Pharmaceutical Manufacturers and Associations, “only 20 percent of [World Health Organization] member states have effective, well-developed drugs regulation systems, and 30 percent of members have no or Read more…

According to the World Health Organisation, 1 medicine out of 10 is fake, and in some countries this figure can reach 7 out of 10. In this brochure, published by Sanofi, learn about falsified medicines and the actions that can be taken to tackle the issue. The brochure outlines key findings from studies carried out across the globe in Latin America (Argentina, Brazil, Guatemala, Ecuador, Peru, Mexico, Colombia)  , Asia (China, Indonesia, Malaysia, the Philippines, Read more…

On 26- 29 June, Rx360 is heading to Memphis, United States to discuss supply chain security at a conference on ‘Protecting Patient Safety in the Global Marketplace. The event is organised by the University of Tennessee Health Sciences Center (UTHSC), with support from different Asia Pacific Economic Cooperation (APEC) bodies responsible for regulatory harmonization and medical products quality across APEC countries. Together, they will launch the Center of Excellence for Global Medical Product Quality & Read more…

Drug counterfeiting has increased significantly in Latin America in recent years. This new Latin America perception study by Sanofi was conducted in December 2016 and is based on the responses of over 7,000 individuals from Argentina, Brazil, Guatemala, Ecuador, Peru, Mexico and Colombia. The purpose of the questions asked is to understand the level of awareness and perception of Latin Americans of the phenomenon of drug counterfeiting. The study shows that 59% of the population questioned Read more…